MoneyWorks4Me

Piramal Phytocare informs about quarterly statement on investor complaint

15 Jan 2016 Evaluate

Piramal Phytocare has informed about quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.65
Dr. Reddys Labs. 1232.75
Cipla 1325.95
Lupin 1935.00
Zydus Lifesciences 1133.85
View more..